Literature DB >> 28199811

FDA Regulation of Prescription Drugs.

Audrey L Gassman1, Christine P Nguyen1, Hylton V Joffe1.   

Abstract

Mesh:

Substances:

Year:  2017        PMID: 28199811     DOI: 10.1056/NEJMra1602972

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  9 in total

1.  Research and Development Spending to Bring a Single Cancer Drug to Market and Revenues After Approval.

Authors:  Vinay Prasad; Sham Mailankody
Journal:  JAMA Intern Med       Date:  2017-11-01       Impact factor: 21.873

2.  Physicians' use of and preferences for FDA-approved prescribing information.

Authors:  Helen W Sullivan; Claudia Squire; Kathryn J Aikin; Janice Tzeng; Kate Ferriola-Bruckenstein; Eric Brodsky; Ann Marie Trentacosti; Mihaela Johnson
Journal:  Res Social Adm Pharm       Date:  2021-08-01

Review 3.  Bronchial thermoplasty-an update.

Authors:  Faria Nasim; Vivek N Iyer
Journal:  Ann Thorac Med       Date:  2018 Oct-Dec       Impact factor: 2.219

4.  Characteristics of non-randomised studies using comparisons with external controls submitted for regulatory approval in the USA and Europe: a systematic review.

Authors:  Sarah Goring; Aliki Taylor; Kerstin Müller; Tina Jun Jian Li; Ellen E Korol; Adrian R Levy; Nick Freemantle
Journal:  BMJ Open       Date:  2019-02-27       Impact factor: 2.692

Review 5.  Performance-Based Risk-Sharing Arrangements (PBRSA): Is it a Solution to Increase Bang for the Buck for Pharmaceutical Reimbursement Strategy for Our Nation and Around the World?

Authors:  Andy Eunwoo Kim; David Hohyun Choi; Jongwha Chang; Sean Hyungwoo Kim
Journal:  Clin Drug Investig       Date:  2020-10-09       Impact factor: 2.859

6.  Pharmacists' perception of educational material to improve patient safety: A cross-sectional study on practices and awareness in Germany.

Authors:  André Said; Leonard Freudewald; Natalie Parrau; Matthias Ganso; Martin Schulz
Journal:  Medicine (Baltimore)       Date:  2021-03-19       Impact factor: 1.817

7.  Readability of information imprinted in patient information leaflets (PILs) in Saudi Arabia: The case of antihypertensive medications.

Authors:  Aljoharah M Algabbani; Shahad A Alzahrani; Salwa M Almomen; Radwan A Hafiz
Journal:  Explor Res Clin Soc Pharm       Date:  2022-09-16

8.  Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and Spending.

Authors:  Olivier J Wouters; Panos G Kanavos; Martin McKEE
Journal:  Milbank Q       Date:  2017-09       Impact factor: 4.911

9.  Is greater generic competition also linked to lower drug prices in South Korea?

Authors:  Kyung-Bok Son
Journal:  Health Econ Rev       Date:  2020-09-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.